<DOC>
	<DOCNO>NCT02518529</DOCNO>
	<brief_summary>Open-label , multicenter study assess 250µg/0.2ml G17DT injection week 0 , 2 6 . At week 20 include week 44 . Subjects raise antibody G17DT give additional dose 125µg/0.1ml 250µg/0.2ml G17DT week 20-44 ( study duration 52 week ) .</brief_summary>
	<brief_title>Study Assess Tolerability Safety Antibody Response G17DT Gastric Cancer Patients</brief_title>
	<detailed_description />
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Gastrins</mesh_term>
	<criteria>Patients curative resection histologically confirm Stage I , II , III gastric carcinoma carcinoma oesophagogastric junciton . Male female patient 18 year age . Patients life expectancy least four month . Karnofsky index performance status &gt; 70 % Patients must give write informed consent . Gastric junctional surgery within three week baseline ( week 0 ) gastric junctional surgery anticipate study period . History malignant disease within previous five year , except nonmelanomatous skin cancer situ carcinoma uterine cervix . Previous use ( within six week prior screen visit study ) , concomitant use , anticipate use ( week 16 ) , chemotherapy immunotherapy . Previous use ( within six week prior screen visit study ) , concomitant use , anticipate use ( week 16 ) , radiotherapy anticancer therapy . Previous use ( within four week prior screen visit study ) , concomitant use , anticipate use ( week 16 ) , immunosuppressant , include systemic corticosteroid . Known immunodeficiency . Females pregnant , plan become pregnant lactating . Women , opinion investigator child bear potential , negative pregnancy test study drug administration . Patients take part another study involve investigational license drug device three month precede enrolment week 16 study . Previous G17DT treatment . Haematological indicator : Haemoglobin &lt; 10.0g/dl Neutrophils &lt; 2.0 x 109/l Platelets &lt; 100 x 109/l</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>